Journal of Vaccine Research, 2025, Vol.15, No.1, 23-33 http://medscipublisher.com/index.php/jvr 30 exploring and innovating in the research and development of preventive and therapeutic vaccines can it be possible to comprehensively control diseases caused by HPV. 8 Concluding Remarks Case reports and clinical investigations have continuously found that HPV infection, especially high-risk types like HPV-16, is closely associated with the occurrence of oral and oropharyngeal canceration. These findings all indicate that preventive measures such as vaccination and early disease detection are particularly crucial for reducing the occurrence of HPV-related oral cancer and improving treatment outcomes. Data also prove that implementing vaccination programs and regular check-ups are effective ways to control the increase of such cancers. Moreover, from the observation of a large number of actual cases, it can be known that early detection and timely treatment of diseases can significantly increase the possibility of patient recovery, and the effect is especially good in people with common HPV infection. These results also indicate that medical personnel such as doctors and dentists must play a more significant role in disease prevention, knowledge dissemination and early identification. At present, the occurrence of HPV-related oral cancer is constantly changing. The number of patients, whether male or female, is on the rise, with men experiencing a faster increase. Therefore, the vaccine plan also needs to be adjusted accordingly. We cannot only pay attention to the group of teenage girls. Other groups of people, such as boys and young men, must also be taken into consideration. Studies show that people who have received the hpv vaccine have a significantly reduced risk of developing HPV-related oral cancer. Moreover, if everyone can be vaccinated, the spread of diseases can be reduced and the overall disease pressure can be alleviated. To make the vaccination strategy more comprehensive, it is also necessary to address the differences in vaccination opportunities and vaccine accessibility among different groups of people, especially in areas with scarce medical resources and high disease risks. Therefore, it is necessary to formulate targeted public health approaches, promote policy updates, ensure the fair distribution of vaccines to everyone, and eliminate differences in disease prevention among different groups. To effectively deal with HPV-related oral cancer, efforts should be made in multiple directions such as vaccination, regular physical examinations, and health promotion. Health promotion activities can help people understand the dangers of HPV, the benefits of vaccination, and the key to early detection of the disease. Regular screening for high-risk groups can help detect diseases earlier and increase the chances of cure. Dentists and doctors play a crucial role in promoting vaccines, popularizing health knowledge, and participating in screening work, which can make preventive measures more extensive and effective. Strengthening collaboration among medical departments, establishing a referral process, and integrating HPV prevention into daily medical services are at the core of enhancing intervention effectiveness. By combining these strategies, the public health system can more effectively reduce the occurrence and mortality of HPV-related oral cancer, enabling patients to achieve more ideal long-term rehabilitation outcomes. Acknowledgments I would like to thank Dr Xia continuous support throughout the development of this study. Conflict of Interest Disclosure The author affirms that this research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest. References Arbyn M., and Xu L., 2018, Efficacy and safety of prophylactic HPV vaccines, a cochrane review of randomized trials, Expert Review of Vaccines, 17(12): 1085-1091. https://doi.org/10.1080/14760584.2018.1548282 Athanasiou A., Bowden S., Paraskevaidi M., Fotopoulou C., Martin-Hirsch P., Paraskevaidis E., and Kyrgiou M., 2020, HPV vaccination and cancer prevention, best practice and research, Clinical Obstetrics and Gynaecology, 65: 109-124. https://doi.org/10.1016/j.bpobgyn.2020.02.009 Bao W.Y., He X.L., Huang Y., Liu R.Y., and Li Z.Y., 2024, The clinical effectiveness of single-dose human papillomavirus vaccination, Vaccines, 12(9): 956. https://doi.org/10.3390/vaccines12090956
RkJQdWJsaXNoZXIy MjQ4ODYzNA==